Exactitude Consultancy
Home Report Store Categories Primary Research Consulting Services Blog Contact us About Us Terms & Conditions Privacy Policy

Needle-Free Injection System Market

May 2022

Base Year Value ()

x.x %
x.x %

CAGR ()

x.x %
x.x %

Forecast Year Value ()

x.x %
x.x %

Historical Data Period

Largest Region

Forecast Period

Mercado de sistemas de inyección sin aguja por tecnología (chorro, resorte, parche de micromatriz), por producto (precargado, rellenable), tipo de medicamento (líquido, polvo), aplicación (vacunación, dermatología), usuarios finales (hospital, atención domiciliaria) y región (Asia-Pacífico, América del Norte, Europa, América del Sur, Oriente Medio y África): pronóstico global de 2022 a 2029

Instant access to hundreds of data points and trends

  • Market estimates from 2014-2029
  • Competitive analysis, industry segmentation, financial benchmarks
  • Incorporates SWOT, Porter's Five Forces and risk management frameworks
  • PDF report or online database with Word, Excel and PowerPoint export options
  • 100% money back guarantee

Descripción general del mercado de sistemas de inyección sin aguja


El tamaño del mercado global del sistema de inyección sin aguja es de USD 105,80 millones en 2020 y se espera que crezca hasta USD 460,74 millones para 2029, a una tasa de crecimiento anual compuesta (CAGR) del 17,90%.

Los inyectores sin aguja ofrecen una mayor seguridad tanto para los pacientes como para los profesionales sanitarios al mitigar los riesgos asociados a los métodos tradicionales de infusión e inyección, como la necesidad de preparar el medicamento, la inserción de la aguja y la manipulación y eliminación de las agujas. Según la Asociación Estadounidense de Enfermeras, aproximadamente el 74,0 % de las lesiones accidentales por pinchazos con agujas son consecuencia de la contaminación, lo que aumenta la probabilidad de infección y puede generar gastos de tratamiento sustanciales.






























































ATRIBUTODETALLES
Periodo de estudio2020-2029
Año base2021
Año estimado2022
Año pronosticado2022-2029
Periodo histórico2018-2020
UnidadValor (millones de USD)
SegmentaciónPor tecnología, Por producto, Por tipo de medicamento, Por aplicación, Por industria de uso final, Por región
Por tecnología

  • Chorro

  • Primavera

  • Parche de micromatriz

  • Otro


Por producto

Por tipo de medicamento

  • Líquido

  • Polvo


Por aplicación

  • Vacunación

  • Dermatología


Por industria de uso final

  • Hospital

  • Cuidado domiciliario


Por región

  • América del norte

  • Europa

  • Asia Pacífico

  • Ministerio de Asuntos Exteriores

  • América Latina



Los Centros para el Control y la Prevención de Enfermedades (CDC) estiman que el costo de tratar las lesiones por pinchazos de agujas oscila entre 500 y 3000 dólares por incidente, con costos aún más altos en casos de infección. Los CDC han proyectado una ocurrencia anual de 385.000 lesiones por pinchazos de agujas en hospitales de Estados Unidos, mientras que la Agencia Europea para la Seguridad y la Salud en el Trabajo informa que se producen aproximadamente 1,0 millón de lesiones de este tipo en todo el mundo cada año.


Los crecientes gastos de atención médica plantean desafíos importantes tanto para las economías en desarrollo como para las desarrolladas, en su esfuerzo por brindar una atención de alta calidad y rentable. A pesar de los programas de apoyo a la financiación y los seguros de salud, los costos de la atención médica en los EE. UU. han seguido aumentando de manera constante, lo que genera preocupación entre los proveedores de atención médica. El gasto en atención médica en los EE. UU. supera el promedio mundial en 2,4 veces y se proyecta que aumentará un 68,0 % durante la próxima década. La adopción de inyectores sin aguja permite a los pacientes autoadministrarse medicamentos por vía subcutánea en la comodidad de sus hogares, lo que potencialmente reduce la frecuencia de las visitas al hospital u otras interacciones con los centros de atención médica. Este enfoque promete ayudar a los pacientes a gestionar y minimizar sus gastos de atención médica de manera efectiva.




[título id="attachment_9618" align="alignleft" width="870"]Needle-Free Injection System Market | Exactitude Consultancy
Mercado de sistemas de inyección sin aguja | Exactitude Consultancy
[/subtítulo]

Frequently Asked Questions

• What is the Size of global Needle-Free Injection System market?

The Needle-Free Injection System market size had crossed USD 105.80 million in 2020 and is expected to grow till USD 460.74 million by 2029.

• Which is the largest regional market for Needle-Free Injection System market?

The Largest Regional market for Needle-Free Injection System market is North America having a market share of 58%.

• What is the CAGR of Needle-Free Injection System market?

The global Needle-Free Injection System market registered a CAGR of 17.90% from 2022 to 2029.

• Which are the top companies to hold the market share in Needle-Free Injection System market?

Key players profiled in the report include PharmaJet, Portal Instruments, Medical International Technology, Inc (MIT), NuGen Medical Devices, Crossject SA, and Bioject Medical Technologies.

• What are the main industries that Needle-Free Injection System are used in?

Hospital, Homecare, and other sectors are among Needle-Free Injection System' key end-use industries.

• What are the factors Driving the growth of Needle-Free Injection System?

Technological Advancement and Increasing demand for self-injection devices to drive the Needle-Free Injection System Market

Needle-Free Injection System Market Segment Analysis

The Needle-Free Injection System market is segmented by Technology, Product, Type of Medication, Application, End Users.

On the basis of Technology, global Needle-Free Injection System market is segmented into Jet, Spring, Micro-array Patch.

On the basis of Type of Medication, global Needle-Free Injection System market is segmented into Prefilled, Fillable.

On the basis of Application, global Needle-Free Injection System market is segmented into Liquid, Powder.

On the basis of End Users, global Needle-Free Injection System market is segmented into Hospital, Homecare.

[caption id="attachment_9587" align="alignleft" width="680"]Needle-Free Injection System Market | Exactitude Consultancy
Needle-Free Injection System Market | Exactitude Consultancy
[/caption]
Needle-Free Injection System Market Players

The Key Players in Needle-Free Injection System Market are PharmaJet, Portal Instruments, Medical International Technology, Inc (MIT), NuGen Medical Devices, Crossject SA, and Bioject Medical Technologies.

Market leaders are putting a premium on new product releases, as well as other organic growth methods like patents and events. Acquisitions, as well as partnerships and collaborations, were considered inorganic growth tactics in the market. As a consequence of these efforts, market participants may now be able to expand their business and client base. In the future, industry participants in the needle-free injection system market are projected to benefit from excellent development opportunities.

Who Should Buy? Or Key Stakeholders

  • Industry and consulting firms
  • State and national regulatory authorities
  • Investors
  • Suppliers and Distributors
  • Research Institutes
  • Others

Key Takeaways:

  • The global Needle-Free Injection System market is expected to grow at a Compound annual growth rate (CAGR) of 17.90%.
  • On the basis of Technology, global Needle-Free Injection System market is segmented into Jet, Spring, Micro-array Patch.
  • On the basis of Type of Medication, global Needle-Free Injection System market is segmented into Prefilled, Fillable.
  • On the basis of Application, global Needle-Free Injection System market is segmented into Liquid, Powder.
  • On the basis of End Users, global Needle-Free Injection System market is segmented into Hospital, Homecare.
  • North America led the needle-free injection market with a 58 percent share.
  • The major trend in the Needle-Free Injection System Market is the growing demand for painless drug delivery methods.

Needle-Free Injection System Market Regional Analysis

Geographically, Needle-Free Injection System market is segmented into North America, Europe, Asia Pacific, and Rest of the world.

  • North America: includes the US, Canada, Mexico
  • Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
  • Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC

North America led the needle-free injection market with a 58 percent share, followed by Europe, Asia Pacific (APAC), Latin America, and the Middle East and Africa. During the projected period, however, the APAC region is predicted to develop at the fastest rate. The rapidly developing healthcare industries in China and India, rising life expectancy, rising per capita income, increasing investments in the region by key market players, the expansion of private-sector hospitals and clinics to rural areas, the availability of low-cost labor for manufacturing, the presence of a favorable regulatory environment, and growing demand for self-injectable device testing are all driving market growth in the APAC region.

[caption id="attachment_9633" align="alignleft" width="680"]Needle-Free Injection System Market | Exactitude Consultancy
Needle-Free Injection System Market | Exactitude Consultancy
[/caption]

Key Market Segments: Needle-Free Injection System Market

Needle-Free Injection System Market by Technology, 2020-2029 (USD Millions)
  • Jet
  • Spring
  • Micro-Array Patch
  • Other
Needle-Free Injection System Market by Product, 2020-2029 (USD Millions)
  • Prefilled
  • Fillable
Needle-Free Injection System Market by Type of Medication, 2020-2029 (USD Millions)
  • Liquid
  • Powder
Needle-Free Injection System Market by Application, 2020-2029 (USD Millions)
  • Vaccination
  • Dermatology
Needle-Free Injection System Market by End Use Industry, 2020-2029 (USD Millions)
  • Hospital
  • Homecare
Needle-Free Injection System Market by Region, 2020-2029 (USD Millions)
  • North America
  • Europe
  • APAC
  • MEA
  • Latin America
Important Countries In All Regions Are Covered.

Objectives of the Study

  • To provide an overall view of the market.
  • To detail out key pointers such as growth, market size, trends, drivers, restraints, challenges and opportunities in quantitative and qualitative terms
  • To provide a holistic view of market players and their activities to get an understanding of key growth strategies adopted

Key Question Answered

  • What is the current market size of this high growth market?
  • What is the overall growth rate?
  • What are the key growth areas, applications, end uses and types?
  • Key reasons for growth
  • Challenges for growth
  • What technological developments are happening in this area?

  1. Introducción

    1. Definición de mercado

    2. Segmentación del mercado

    3. Cronología de la investigación

    4. Supuestos y limitaciones



  2. Metodología de la investigación

    1. Minería de datos

      1. Investigación secundaria

      2. Investigación primaria

      3. Asesoramiento de expertos en la materia



    2. Controles de calidad

      1. Revisión final



    3. Triangulación de datos

      1. Enfoque de abajo hacia arriba

      2. Enfoque de arriba hacia abajo

      3. Flujo de investigación



    4. Fuentes de datos



  3. Resumen ejecutivo

  4. Descripción general del mercado

    1. Perspectivas del mercado mundial de sistemas de inyección sin agujas

      1. Factores impulsores del mercado

      2. Restricciones del mercado

      3. Oportunidades de mercado



    2. Impacto de Covid-19 en el mercado de sistemas de inyección sin aguja

    3. Las cinco fuerzas de Porter Tipo

      1. Amenaza de nuevos participantes

      2. Amenaza de sustitutos

      3. Poder de negociación de los proveedores

      4. Poder de negociación de los clientes

      5. Grado de competencia



    4. Análisis de la cadena de valor de la industria



  5. Mercado mundial de sistemas de inyección sin aguja por tecnología

    1. Chorro

    2. Primavera

    3. Parche de micromatriz

    4. Otro



  6. Mercado mundial de sistemas de inyección sin aguja por producto

    1. Prellenado

    2. Rellenable



  7. Mercado mundial de sistemas de inyección sin aguja por tipo de medicamento

    1. Líquido

    2. Polvo



  8. Mercado mundial de sistemas de inyección sin aguja por aplicación

    1. Vacunación

    2. Dermatología



  9. Mercado mundial de sistemas de inyección sin aguja por industria de uso final

    1. Hospital

    2. Cuidado domiciliario



  10. Mercado mundial de sistemas de inyección sin aguja por región

    1. América del norte

      1. A NOSOTROS

      2. Canadá

      3. México



    2. Sudamerica

      1. Brasil

      2. Argentina

      3. Colombia

      4. Resto de Sudamérica



    3. Europa

      1. Alemania

      2. Reino Unido

      3. Francia

      4. Italia

      5. España

      6. Rusia

      7. Resto de Europa



    4. Asia Pacífico

      1. India

      2. Porcelana

      3. Japón

      4. Corea del Sur

      5. Australia

      6. Sudeste asiático

      7. Resto de Asia Pacífico



    5. Oriente Medio y África

      1. Emiratos Árabes Unidos

      2. Arabia Saudita

      3. Sudáfrica

      4. Resto de Oriente Medio y África







  1. Perfiles de empresas* (descripción general de la empresa, descripción general de la empresa, productos ofrecidos, desarrollos recientes)



  1. Farmacia Jet

  2. Instrumentos del portal

  3. Tecnología Médica Internacional, Inc. (MIT)

  4. Dispositivos médicos NuGen

  5. Crossject SA Bioject Medical Technologies  *La lista de empresas es indicativa


 

LISTA DE TABLAS


TABLE 1           GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 2           GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 3           GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 4           GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 5           GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 6           GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY REGION (USD MILLIONS) 2020-2029

TABLE 7           US INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 8           US INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 9           US INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 10        US INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 11        US INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 12        CANADA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 13        CANADA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 14        CANADA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 15        CANADA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 16        CANADA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 17        MEXICO INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 18        MEXICO INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 19        MEXICO INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 20        MEXICO INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 21        MEXICO INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 22        BRAZIL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 23        BRAZIL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 24        BRAZIL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 25        BRAZIL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 26        BRAZIL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 27        ARGENTINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 28        ARGENTINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 29        ARGENTINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 30        ARGENTINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 31        ARGENTINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 32        COLOMBIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 33        COLOMBIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 34        COLOMBIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 35        COLOMBIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 36        COLOMBIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 37        REST OF SOUTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 38        REST OF SOUTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 39        REST OF SOUTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 40        REST OF SOUTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 41        REST OF SOUTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 42        INDIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 43        INDIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 44        INDIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 45        INDIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 46        INDIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 47        CHINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 48        CHINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 49        CHINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 50        CHINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 51        CHINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 52        JAPAN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 53        JAPAN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 54        JAPAN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 55        JAPAN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 56        JAPAN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 57        SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 58        SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 59        SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 60        SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 61        SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 62        AUSTRALIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 63        AUSTRALIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 64        AUSTRALIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 65        AUSTRALIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 66        AUSTRALIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 67        SOUTH-EAST ASIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 68        SOUTH-EAST ASIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 69        SOUTH-EAST ASIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 70        SOUTH-EAST ASIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 71        SOUTH-EAST ASIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 72        REST OF ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 73        REST OF ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 74        REST OF ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 75        REST OF ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 76        REST OF ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 77        GERMANY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 78        GERMANY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 79        GERMANY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 80        GERMANY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 81        GERMANY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 82        UK INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 83        UK INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 84        UK INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 85        UK INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 86        UK INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 87        FRANCE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 88        FRANCE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 89        FRANCE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 90        FRANCE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 91        FRANCE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 92        ITALY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 93        ITALY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 94        ITALY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 95        ITALY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 96        ITALY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 97        SPAIN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 98        SPAIN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 99        SPAIN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 100      SPAIN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 101      SPAIN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 102      RUSSIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 103      RUSSIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 104      RUSSIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 105      RUSSIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 106      RUSSIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 107      REST OF EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 108      REST OF EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 109      REST OF EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 110      REST OF EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 111      REST OF EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 112      UAE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 113      UAE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 114      UAE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 115      UAE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 116      UAE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 117      SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 118      SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 119      SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 120      SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 121      SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 122      SOUTH AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 123      SOUTH AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 124      SOUTH AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 125      SOUTH AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 126      SOUTH AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 127      REST OF MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 128      REST OF MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 129      REST OF MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 130      REST OF MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 131      REST OF MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

 

LIST OF FIGURES


FIGURE 1              MARKET DYNAMICS

FIGURE 2              MARKET SEGMENTATION

FIGURE 3              REPORT TIMELINES: YEARS CONSIDERED

FIGURE 4              DATA TRIANGULATION

FIGURE 5              BOTTOM-UP APPROACH

FIGURE 6              TOP-DOWN APPROACH

FIGURE 7              RESEARCH FLOW

FIGURE 8        GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET BY TECHNOLOGY, USD MILLION, 2020-2029

FIGURE 9        GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET BY PRODUCT USD MILLION, 2020-2029

FIGURE 10     GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET BY TYPE OF MEDICATIONR, USD MILLION, 2020-2029

FIGURE 11     GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET BY TECHNOLOGY, USD MILLION, 2020-2029

FIGURE 13     GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET BY REGION, USD MILLION, 2020-2029

FIGURE 12     PORTER’S FIVE FORCES TYPE

FIGURE 13     NORTH AMERICA NEEDLE-FREE INJECTION SYSTEM MARKET SNAPSHOT

FIGURE 14     EUROPE NEEDLE-FREE INJECTION SYSTEM MARKET SNAPSHOT

FIGURE 15     ASIA PACIFIC NEEDLE-FREE INJECTION SYSTEM MARKET SNAPSHOT

FIGURE 16           SOUTH AMERICA NEEDLE-FREE INJECTION SYSTEM MARKET SNAPSHOT

FIGURE 17           MIDDLE EAST & AFRICA NEEDLE-FREE INJECTION SYSTEM MARKET SNAPSHOT

FIGURE 18           PHARMAJETCOMPANY SNAPSHOT

FIGURE 19           PORTAL INSTRUMENTSCOMPANY SNAPSHOT

FIGURE 20           MEDICAL INTERNATIONAL TECHNOLOGY, INC (MIT)COMPANY SNAPSHOT

FIGURE 21           NUGEN MEDICAL DEVICESCOMPANY SNAPSHOT

FIGURE 22           CROSSJECT SA BIOJECT MEDICAL TECHNOLOGIESCOMPANY SNAPSHOT

DOWNLOAD FREE SAMPLE REPORT

Kindly share your specific requirement (if any)
9621

License Type

Single User

US$ 3499

Multi User

US$ 4499

Corporate User

US$ 5499

Get Sample to Email

SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

WANT TO CUSTOMIZE THE REPORT?

Our Clients Speak

We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te

Yosuke Mitsui

Senior Associate Construction Equipment Sales & Marketing

We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te

Yosuke Mitsui

Senior Associate Construction Equipment Sales & Marketing

Why choose us

Proactive

We manage our resources 24/7 to identify issues and address them before they become problems

Quality & Reliability

We are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach

6 Major regions and 40+ countries level analysis accomplished

Competitive Pricing

Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

In-Depth Database

In-Depth Database

Our Report’s database covers almost all topics of all regions over the Globe.

Recognised Publishing Sources

Recognised Publishing Sources

Tie ups with top publishers around the globe.

Customer Support

Customer Support

Complete pre and post sales support.

Safe & Secure

Safe & Secure

Complete secure payment process.